These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30662556)

  • 1. Redox Dual-Responsive and O
    Chen H; Li F; Yao Y; Wang Z; Zhang Z; Tan N
    Theranostics; 2019; 9(1):90-103. PubMed ID: 30662556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy.
    Yue C; Zhang C; Alfranca G; Yang Y; Jiang X; Yang Y; Pan F; de la Fuente JM; Cui D
    Theranostics; 2016; 6(4):456-69. PubMed ID: 26941840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Luminescing Theranostic Nanoreactors with Intraparticle Relayed Energy Transfer for Tumor Microenvironment Activated Imaging and Photodynamic Therapy.
    Wu M; Wu L; Li J; Zhang D; Lan S; Zhang X; Lin X; Liu G; Liu X; Liu J
    Theranostics; 2019; 9(1):20-33. PubMed ID: 30662551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
    Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
    Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
    Yang X; Shi X; Ji J; Zhai G
    Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.
    Li Y; Li Y; Zhang X; Xu X; Zhang Z; Hu C; He Y; Gu Z
    Theranostics; 2016; 6(9):1293-305. PubMed ID: 27375780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity.
    Xu Z; Qian J; Meng C; Liu Y; Ding Q; Wu H; Li P; Ran F; Liu GQ; Wang Y; Ling Y
    Theranostics; 2022; 12(6):2535-2548. PubMed ID: 35401826
    [No Abstract]   [Full Text] [Related]  

  • 13. A Simple Glutathione-Responsive Turn-On Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy.
    Li Y; Wu Y; Chen J; Wan J; Xiao C; Guan J; Song X; Li S; Zhang M; Cui H; Li T; Yang X; Li Z; Yang X
    Nano Lett; 2019 Aug; 19(8):5806-5817. PubMed ID: 31331172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles.
    Jin G; He R; Liu Q; Lin M; Dong Y; Li K; Tang BZ; Liu B; Xu F
    Theranostics; 2019; 9(1):246-264. PubMed ID: 30662565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancer.
    Chen H; Yao Y; Zhao X; Tan N
    Biomater Sci; 2023 Oct; 11(21):7114-7123. PubMed ID: 37671612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.
    Nisar S; Starosta E; Elayyan M; Regmi A; Sui B
    ACS Appl Mater Interfaces; 2024 Feb; 16(6):6859-6867. PubMed ID: 38299497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
    Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
    Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mesoporous theranostic platform for ultrasound and photoacoustic dual imaging-guided photothermal and enhanced starvation therapy for cancer.
    Liang X; Chen W; Wang C; Jiang K; Zhu J; Lu R; Lin Z; Cao Z; Zheng J
    Acta Biomater; 2024 Jul; 183():264-277. PubMed ID: 38815685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.